Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Infections in Children and Adolescents: Course of COVID-19, Immune Responses, Complications and Long-term Consequences in Entire Households With Members Younger Than 18 Years

NCT04741412 is registered in ClinicalTrials.gov with University Hospital Erlangen as lead sponsor.

NCT NCT04741412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04741412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Infections in Children and Adolescents: Course of COVID-19, Immune Responses, Complications and Long-term Consequences in Entire Households With Members Younger Than 18 Years
Lead sponsor
University Hospital Erlangen
Phase
Observational
Overall status
Completed
Start date
June 3, 2020
Completion date
May 31, 2021
Enrollment
231 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypohidrotic ectodermal dysplasia